Latest Deals

Mattioli Woods snaps up Opus Wealth Management 

Specialist wealth and asset management business Mattioli Woods has announced its subsidiary Ludlow Wealth Management has acquired Opus for an initial £0.71m ($880,400). 

There is a potential further consideration of up to £0.71m depending on specific performance targets in the year after completion. 

Opus is based in Blackpool and provides financial planning and wealth management to around 100 private client families with approximately £53m of assets under advice. 

Source: Pharmaceutical Technology

ICG makes €400m investment in Enfinity Global 

Asset manager ICG has revealed that its infrastructure team has reached an agreement to invest €400m ($428m) in Enfinity Global, an innovator in the renewable energy industry, to support the expansion and business strategy.

Source: Pharmaceutical Technology

Evelyn Partners finishes the acquisition of Dart Capital 

Evelyn Partners reports that it has successfully acquired Dart Capital, a City of London-based boutique wealth manager after receiving regulatory approval. Dart Capital is an accredited business that was founded in 1987 and offers individualised advice and discretionary investment management services to a select group of clients, including partners of top law and accounting firms, senior executives, entrepreneurs, and retirees. Furthermore, it has a team of 19 employees and £750m in assets under management. 

Source: Pharmaceutical Technology

Creative Planning agrees to buy Goldman Sachs Personal Financial Management 

Goldman Sachs Group has sold its Personal Financial Management (PFM) subsidiary to Creative Planning (Creative). Goldman Sachs Asset Management is going to continue to provide investment solutions and services to Creative’s wealth management teams even while the company develops an innovative investment management platform. With over 2,100 people spread throughout its affiliates and $245bn in assets under management and advisory, Creative is a Registered Investment Advisor (RIA) in the sector. 

Source: Pharmaceutical Technology